Evidence map›Paper›PMID 29302365›Full record

ArticleNPJ Regenerative medicine2017

Intraoperative delivery of the Notch ligand Jagged-1 regenerates appendicular and craniofacial bone defects.

Daniel W Youngstrom, Rafael Senos, Robert L Zondervan, Jack D Brodeur, Austin R Lints, Devin R Young, Troy L Mitchell, Megan E Moore, Marc H Myers, Wei-Ju Tseng and 2 more

Open access · goldAbstract read
In one paragraph

Article in NPJ Regenerative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. PDGF inhibits BMP2-induced bone healing.NPJ Regenerative medicine · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Modulation of Notch1 signaling regulates bone fracture healing.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Daniel W YoungstromOrthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan Medical School, Ann Arbor, MI USA.
Rafael SenosOrthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan Medical School, Ann Arbor, MI USA.
Robert L ZondervanOrthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan Medical School, Ann Arbor, MI USA.
Jack D BrodeurDepartment of Physiology, Michigan State University College of Osteopathic Medicine, East Lansing, MI USA.
Austin R LintsDepartment of Physiology, Michigan State University College of Osteopathic Medicine, East Lansing, MI USA.
Devin R YoungDepartment of Physiology, Michigan State University College of Osteopathic Medicine, East Lansing, MI USA.
Troy L MitchellOrthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan Medical School, Ann Arbor, MI USA.
Megan E MooreDepartment of Physiology, Michigan State University College of Osteopathic Medicine, East Lansing, MI USA.
Marc H MyersDepartment of Orthopaedic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA USA.
Wei-Ju TsengDepartment of Orthopaedic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA USA.
Kathleen M LoomesDivision of Gastroenterology, Hepatology and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, PA USA.
Kurt D HankensonOrthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan Medical School, Ann Arbor, MI USA.ORCID 0000-0001-6361-143X
University of Michigan · USMichigan State University · USUniversity of Pennsylvania · USChildren's Hospital of Philadelphia · US

Funding

INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR024134 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2006 to 2011
$70.4M
Overall: Resource-based Center for Musculoskeletal Disorders Research (Overall Application)P30AR069619 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI LOUIS J SOSLOWSKY · 2016 to 2026
$9.1M
Notch-induced intramembranous bone regenerationF32DE026346 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI YOUNGSTROM, DANIEL WARREN · 2016 to 2018
$176k
Disruption of CD47 signaling promotes healing in ischemic fractures and bone allograftsF30AR071201 · NIAMS · MICHIGAN STATE UNIVERSITY · PI ZONDERVAN, ROBERT LOUIS · 2017 to 2019
$126k
NCRR NIH HHS UL1 RR024134NIAMS NIH HHS F30 AR071201NIAMS NIH HHS P30 AR069619NIDCR NIH HHS F32 DE026346
6 · The paper itself

Abstract

Each year, 33% of US citizens suffer from a musculoskeletal condition that requires medical intervention, with direct medical costs approaching $1 trillion USD per year. Despite the ubiquity of skeletal dysfunction, there are currently limited safe and efficacious bone growth factors in clinical use. Notch is a cell-cell communication pathway that regulates self-renewal and differentiation within the mesenchymal/osteoblast lineage. The principal Notch ligand in bone, Jagged-1, is a potent osteoinductive protein that positively regulates post-traumatic bone healing in animals. This report describes the temporal regulation of Notch during intramembranous bone formation using marrow ablation as a model system and demonstrates decreased bone formation following disruption of Jagged-1 in mesenchymal progenitor cells. Notch gain-of-function using recombinant Jagged-1 protein on collagen scaffolds promotes healing of craniofacial (calvarial) and appendicular (femoral) surgical defects in both mice and rats. Localized delivery of Jagged-1 promotes bone apposition and defect healing, while avoiding the diffuse bone hypertrophy characteristic of the clinically problematic bone morphogenetic proteins. It is concluded that Jagged-1 is a bone-anabolic agent with therapeutic potential for regenerating traumatic or congenital bone defects.

Identifiers

PMID29302365
PMCPMC5732299
OpenAlexW2774019875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.